Concepedia

Rajendra K. Pandey

RK

14

Publications

2K

Citations

14

H-Index

2003

Active since

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Vanderbilt University

Binghamton University

Spring Bank Pharmaceuticals (United States)

Rajendra K. Pandey is an author at Alnylam Pharmaceuticals (United States) specializing in medicine, immunology, and engineering.

ORCID

Top concepts

Publications per year

2003–2021

14

Publications

14

Mechanisms and optimization of in vivo delivery of lipophilic siRNAs

Christian Wolfrum, Shuanping Shi, K. N. Jayaprakash et al. · Nature Biotechnology · 2007 · 958 citations

, , +7

Unexpected origins of the enhanced pairing affinity of 2′-fluoro-modified RNA

Pradeep S. Pallan, Emily M. Greene, Paul Andrei Jicman et al. · Nucleic Acids Research · 2010 · 191 citations · Full text

Unique Gene‐Silencing and Structural Properties of 2′‐Fluoro‐Modified siRNAs

Muthiah Manoharan, Akin Akinc, Rajendra K. Pandey et al. · Angewandte Chemie International Edition · 2011 · 184 citations

RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy

Rene Alvarez, Sayda M. Elbashir, Todd Borland et al. · Antimicrobial Agents and Chemotherapy · 2009 · 144 citations · Full text

, , +16

In vivo silencing of alpha-synuclein using naked siRNA

Jada Lewis, Heather L. Melrose, David Bumcrot et al. · Molecular Neurodegeneration · 2008 · 143 citations · Full text

Rows per page

1–5 of 14